logo

SNOA

Sonoma Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)

SNOA fundamentals

Sonoma Pharmaceuticals (SNOA) released its earnings on Aug 7, 2025: revenue was 4.01M (YoY +18.40%), missed estimates; EPS was -0.3694 (YoY +70.80%), beat estimates.
Revenue / YoY
4.01M
+18.40%
EPS / YoY
-0.3694
+70.80%
Report date
Aug 7, 2025

Earnings

EPS
Revenue

Revenue & Expenses

SNOA has released its 2026 Q3 earnings report, with revenue of 4.35M, reflecting a YoY change of 22.03%, and net profit of -819.00K, showing a YoY change of 11.75%. The Sankey diagram below clearly presents SNOA's revenue sources and cost distribution.

Key Indicators

Sonoma Pharmaceuticals (SNOA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Sonoma Pharmaceuticals (SNOA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Sonoma Pharmaceuticals (SNOA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Sonoma Pharmaceuticals (SNOA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Sonoma Pharmaceuticals (SNOA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Sonoma Pharmaceuticals (SNOA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield